Literature DB >> 20386992

Impact of interim methadone maintenance on HIV risk behaviors.

Monique E Wilson1, Robert P Schwartz, Kevin E O'Grady, Jerome H Jaffe.   

Abstract

The extent to which interim methadone (IM) without counseling reduces HIV risk behavior has not been reported. The AIDS Risk Assessment scale was administered at baseline and 4-month follow-up to 319 adult heroin-dependent participants randomly assigned to IM or waiting list. On an intent-to-treat basis, there was a significantly greater reduction in drug injection and unprotected sex while high from baseline to follow-up, favoring the IM condition. Remedying the shortage of methadone capacity through the expansion of IM would be a worthwhile approach to reducing the spread of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386992      PMCID: PMC2900571          DOI: 10.1007/s11524-010-9451-7

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  13 in total

1.  HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.

Authors:  David C Lott; Eric C Strain; Robert K Brooner; George E Bigelow; Rolley E Johnson
Journal:  J Subst Abuse Treat       Date:  2006-07-18

2.  Reducing the risk of AIDS through methadone maintenance treatment.

Authors:  J C Ball; W R Lange; C P Myers; S R Friedman
Journal:  J Health Soc Behav       Date:  1988-09

3.  Psychosocial correlates of AIDS-risk drug use and sexual behaviors.

Authors:  D D Simpson; K Knight; S Ray
Journal:  AIDS Educ Prev       Date:  1993

Review 4.  Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda R Gowing; Michael Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert L Ali
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

5.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

6.  Assessment of an AIDS intervention program during drug abuse treatment.

Authors:  J F Boatler; K Knight; D D Simpson
Journal:  J Subst Abuse Treat       Date:  1994 Jul-Aug

7.  Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants.

Authors:  N Galai; M Safaeian; D Vlahov; A Bolotin; D D Celentano
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

8.  Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.

Authors:  D S Metzger; G E Woody; A T McLellan; C P O'Brien; P Druley; H Navaline; D DePhilippis; P Stolley; E Abrutyn
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-09

9.  Psychological dysfunction and HIV/AIDS risk behavior.

Authors:  L M Camacho; B S Brown; D D Simpson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-02-01

10.  Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men.

Authors:  Donald A Calsyn; Mary Hatch-Maillette; Susan Tross; Suzanne R Doyle; Paul Crits-Christoph; Yong S Song; Judy M Harrer; Genise Lalos; Sara B Berns
Journal:  J Subst Abuse Treat       Date:  2009-01-15
View more
  11 in total

1.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

2.  Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

3.  Barriers to health and social services for street-involved youth in a Canadian setting.

Authors:  Brittany Barker; Thomas Kerr; Paul Nguyen; Evan Wood; Kora DeBeck
Journal:  J Public Health Policy       Date:  2015-03-26       Impact factor: 2.222

4.  Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E Oʼgrady; Devang Gandhi; Jerome H Jaffe
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

5.  Patterns in admission delays to outpatient methadone treatment in the United States.

Authors:  Jan Gryczynski; Robert P Schwartz; David S Salkever; Shannon Gwin Mitchell; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-08-06

6.  Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Authors:  Robert P Schwartz; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Addict Dis       Date:  2015

7.  Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.

Authors:  Monique E Wilson; Timothy W Kinlock; Michael S Gordon; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2012 Sep-Oct

Review 8.  A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.

Authors:  Frances R Levin; Adam Bisaga; Maria A Sullivan; Arthur Robin Williams; Kathryn Cates-Wessel
Journal:  Am J Addict       Date:  2016-11-02

9.  Within-subject evaluation of interim buprenorphine treatment during waitlist delays.

Authors:  Tatum N Oleskowicz; Taylor A Ochalek; Kelly R Peck; Gary J Badger; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2021-01-20       Impact factor: 4.492

10.  Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.

Authors:  Stephen W Patrick; Michael R Richards; William D Dupont; Elizabeth McNeer; Melinda B Buntin; Peter R Martin; Matthew M Davis; Corey S Davis; Katherine E Hartmann; Ashley A Leech; Kim S Lovell; Bradley D Stein; William O Cooper
Journal:  JAMA Netw Open       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.